The Advertiser friday May 17 2013
Bionomics and the co-operative Research Centre for Cancer Therapeutics have proved they have a compound which can inhibit lymphatic vessel growth, therefore slowing the spread of cancer.
Bionomics chief executive Deborah Rathjen said such compounds "have potential in the treatment of melanoma and in breast cancer"
Add to My Watchlist
What is My Watchlist?